Role of Anemia in Progression of Chronic Kidney Disease

Seminars in Nephrology

Volumn 26, Issue 4, 2006, Pages 283-289

  Rossert, Jerome ^a   Froissart, Marc ^a  

^a UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

anemia; chronic kidney disease; erythropoietin; hypoxia; progression

Indexed keywords

ANGIOTENSIN 2 RECEPTOR ANTAGONIST; LOSARTAN;

ANALYSIS; ANEMIA; ANTIOXIDANT ACTIVITY; ARTICLE; BLOOD; CELL HYPOXIA; CHRONIC KIDNEY DISEASE; CLINICAL STUDY; COHORT ANALYSIS; DISEASE ACTIVITY; ERYTHROCYTE; EXPERIMENTAL STUDY; GLOMERULOSCLEROSIS; GLOMERULUS FILTRATION RATE; HUMAN; HYPOTHESIS; INTERSTITIAL NEPHRITIS; INTERVENTION STUDY; KIDNEY DYSFUNCTION; KIDNEY FAILURE; KIDNEY TUBULE CELL; NON INSULIN DEPENDENT DIABETES MELLITUS; OBSERVATIONAL STUDY; OXIDATIVE STRESS; PATHOGENESIS; POST HOC ANALYSIS; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR;

ANEMIA; ANIMALS; ANOXIA; HUMANS; KIDNEY FAILURE, CHRONIC; OXIDATIVE STRESS;

EID: 33751055577     PISSN: 02709295     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.semnephrol.2006.05.004     Document Type: Article

References (82)

1. Astor B.C., Muntner P., Levin A., et al. Association of kidney function with anemia: The Third National Health and Nutrition Examination Survey (1988-1994). Arch Intern Med 162 (2002) 1401-1408
2. Grune T., Sommerburg O., and Siems W.G. Oxidative stress in anemia. Clin Nephrol 53 (2000) S18-S22
3. Brenner B.M., Meyer T.W., and Hostetter T.H. Dietary protein intake and the progressive nature of kidney disease: The role of hemodynamically mediated glomerular injury in the pathogenesis of progressive glomerular sclerosis in aging, renal ablation, and intrinsic renal disease. N Engl J Med 307 (1982) 652-659
4. Dworkin L.D., Hostetter T.H., Rennke H.G., et al. Hemodynamic basis for glomerular injury in rats with desoxycorticosterone-salt hypertension. J Clin Invest 73 (1984) 1448-1461
5. Anderson S., Meyer T.W., Rennke H.G., et al. Control of glomerular hypertension limits glomerular injury in rats with reduced renal mass. J Clin Invest 76 (1985) 612-619
6. Zatz R., Meyer T.W., Rennke H.G., et al. Predominance of hemodynamic rather than metabolic factors in the pathogenesis of diabetic glomerulopathy. Proc Natl Acad Sci U S A 82 (1985) 5963-5967
7. Remuzzi A., Mazerska M., Gephardt G.N., et al. Three-dimensional analysis of glomerular morphology in patients with subtotal nephrectomy. Kidney Int 48 (1995) 155-162
8. Nath K.A. Tubulointerstitial changes as a major determinant in the progression of renal damage. Am J Kidney Dis 20 (1992) 1-17
9. Mackensen-Haen S., Eissele R., and Bohle A. Contribution on the correlation between morphometric parameters gained from the renal cortex and renal function in IgA nephritis. Lab Invest 59 (1988) 239-244
10. Wehrmann M., Bohle A., Bogenschutz O., et al. Long-term prognosis of chronic idiopathic membranous glomerulonephritis. An analysis of 334 cases with particular regard to tubulo-interstitial changes. Clin Nephrol 31 (1989) 67-76
11. Bogenschutz O., Bohle A., Batz C., et al. IgA nephritis: On the importance of morphological and clinical parameters in the long-term prognosis of 239 patients. Am J Nephrol 10 (1990) 137-147
12. Wehrmann M., Bohle A., Held H., et al. Long-term prognosis of focal sclerosing glomerulonephritis. An analysis of 250 cases with particular regard to tubulointerstitial changes. Clin Nephrol 33 (1990) 115-122
13. Mackensen-Haen S., Bader R., Grund K.E., et al. Correlations between renal cortical interstitial fibrosis, atrophy of the proximal tubules and impairment of the glomerular filtration rate. Clin Nephrol 15 (1981) 167-171
14. Marcussen N. Atubular glomeruli and the structural basis for chronic renal failure. Lab Invest 66 (1992) 265-284
15. Gandhi M., Olson J.L., and Meyer T.W. Contribution of tubular injury to loss of remnant kidney function. Kidney Int 54 (1998) 1157-1165
16. Yamamoto K., Tomita N., Yoshimura S., et al. Hypoxia-induced renal epithelial cell death through caspase-dependent pathway: Role of Bcl-2, Bcl-xL and Bax in tubular injury. Int J Mol Med 14 (2004) 633-640
17. Hotter G., Palacios L., and Sola A. Low O2 and high CO2 in LLC-PK1 cells culture mimics renal ischemia-induced apoptosis. Lab Invest 84 (2004) 213-220
18. Cachat F., Lange-Sperandio B., Chang A.Y., et al. Ureteral obstruction in neonatal mice elicits segment-specific tubular cell responses leading to nephron loss. Kidney Int 63 (2003) 564-575
19. Khan S., Cleveland R.P., Koch C.J., et al. Hypoxia induces renal tubular epithelial cell apoptosis in chronic renal disease. Lab Invest 79 (1999) 1089-1099
20. Beeri R., Symon Z., Brezis M., et al. Rapid DNA fragmentation from hypoxia along the thick ascending limb of rat kidneys. Kidney Int 47 (1995) 1806-1810
21. Allen J., Winterford C., Axelsen R.A., et al. Effects of hypoxia on morphological and biochemical characteristics of renal epithelial cell and tubule cultures. Ren Fail 14 (1992) 453-460
22. Remuzzi G., and Bertani T. Pathophysiology of progressive nephropathies. N Engl J Med 339 (1998) 1448-1456
23. Eddy A.A., and Giachelli C.M. Renal expression of genes that promote interstitial inflammation and fibrosis in rats with protein-overload proteinuria. Kidney Int 47 (1995) 1546-1557
24. Fine L.G., Ong A.C., and Norman J.T. Mechanisms of tubulo-interstitial injury in progressive renal diseases. Eur J Clin Invest 23 (1993) 259-265
25. Eckardt K.-U., Bernhardt W.M., Weidemann A., et al. Role of hypoxia in the pathogenesis of renal disease. Kidney Int 68 (2005) S46-S51
26. Welch W.J., Baumgartl H., Lubbers D., et al. Nephron pO2 and renal oxygen usage in the hypertensive rat kidney. Kidney Int 59 (2001) 230-237
27. Lubbers D.W., and Baumgartl H. Heterogeneities and profiles of oxygen pressure in brain and kidney as examples of the pO2 distribution in the living tissue. Kidney Int 51 (1997) 372-380
28. Zhang W., and Edwards A. Oxygen transport across vasa recta in the renal medulla. Am J Physiol 283 (2002) H1042-H1055
29. Brezis M., and Rosen S. Hypoxia of the renal medulla-its implications for disease. N Engl J Med 332 (1995) 647-655
30. Matsumoto M., Tanaka T., Yamamoto T., et al. Hypoperfusion of peritubular capillaries induces chronic hypoxia before progression of tubulointerstitial injury in a progressive model of rat glomerulonephritis. J Am Soc Nephrol 15 (2004) 1574-1581
31. Manotham K., Tanaka T., Matsumoto M., et al. Evidence of tubular hypoxia in the early phase in the remnant kidney model. J Am Soc Nephrol 15 (2004) 1277-1288
32. Izuhara Y., Nangaku M., Inagi R., et al. Renoprotective properties of angiotensin receptor blockers beyond blood pressure lowering. J Am Soc Nephrol 16 (2005) 3631-3641
33. Tanaka T., Miyata T., Inagi R., et al. Hypoxia in renal disease with proteinuria and/or glomerular hypertension. Am J Pathol 165 (2004) 1979-1992
34. Tsai A.G., Johnson P.C., and Intaglietta M. Oxygen gradients in the microcirculation. Physiol Rev 83 (2003) 933-963
35. Ries M., Basseau F., Tyndal B., et al. Renal diffusion and BOLD MRI in experimental diabetic nephropathy. Blood oxygen level-dependent. J Magn Reson Imaging 17 (2003) 104-113
36. Aiello S., Remuzzi G., and Noris M. Nitric oxide/endothelin balance after nephron reduction. Kidney Int Suppl 65 (1998) S63-S67
37. Ohashi R., Shimizu A., Masuda Y., et al. Peritubular capillary regression during the progression of experimental obstructive nephropathy. J Am Soc Nephrol 13 (2002) 1795-1805
38. Ohashi R., Kitamura H., and Yamanaka N. Peritubular capillary injury during the progression of experimental glomerulonephritis in rats. J Am Soc Nephrol 11 (2000) 47-56
39. Kang D.H., Hughes J., Mazzali M., et al. Impaired angiogenesis in the remnant kidney model: II. Vascular endothelial growth factor administration reduces renal fibrosis and stabilizes renal function. J Am Soc Nephrol 12 (2001) 1448-1457
40. Bohle A., Mackensen-Haen S., and Wehrmann M. Significance of postglomerular capillaries in the pathogenesis of chronic renal failure. Kidney Blood Press Res 19 (1996) 191-195
41. Choi Y.J., Chakraborty S., Nguyen V., et al. Peritubular capillary loss is associated with chronic tubulointerstitial injury in human kidney: Altered expression of vascular endothelial growth factor. Hum Pathol 31 (2000) 1491-1497
42. Kang D.H., Kanellis J., Hugo C., et al. Role of the microvascular endothelium in progressive renal disease. J Am Soc Nephrol 13 (2002) 806-816
43. Crawford S.E., Stellmach V., Murphy-Ullrich J.E., et al. Thrombospondin-1 is a major activator of TGF-beta1 in vivo. Cell 93 (1998) 1159-1170
44. Kang D.H., Joly A.H., Oh S.W., et al. Impaired angiogenesis in the remnant kidney model: I. Potential role of vascular endothelial growth factor and thrombospondin-1. J Am Soc Nephrol 12 (2001) 1434-1447
45. Hugo C., Shankland S.J., Pichler R.H., et al. Thrombospondin 1 precedes and predicts the development of tubulointerstitial fibrosis in glomerular disease in the rat. Kidney Int 53 (1998) 302-311
46. Tanaka T., Hanafusa N., Ingelfinger J.R., et al. Hypoxia induces apoptosis in SV40-immortalized rat proximal tubular cells through the mitochondrial pathways, devoid of HIF1-mediated upregulation of Bax. Biochem Biophys Res Commun 309 (2003) 222-231
47. Lieberthal W., Menza S.A., and Levine J.S. Graded ATP depletion can cause necrosis or apoptosis of cultured mouse proximal tubular cells. Am J Physiol 274 (1998) F315-F327
48. Feldenberg L.R., Thevananther S., del Rio M., et al. Partial ATP depletion induces Fas- and caspase-mediated apoptosis in MDCK cells. Am J Physiol 276 (1999) F837-F846
49. Lieberthal W., and Levine J.S. Mechanisms of apoptosis and its potential role in renal tubular epithelial cell injury. Am J Physiol 271 (1996) F477-F488
50. He C., Zalups R.K., Henderson D.A., et al. Molecular analysis of spontaneous glomerulosclerosis in Os/+ mice, a model with reduced nephron mass. Am J Physiol 269 (1995) F266-F273
51. Nir A., Clavell A.L., Heublein D., et al. Acute hypoxia and endogenous renal endothelin. J Am Soc Nephrol 4 (1994) 1920-1924
52. Higgins D.F., Biju M.P., Akai Y., et al. Hypoxic induction of Ctgf is directly mediated by Hif-1. Am J Physiol 287 (2004) F1223-F1232
53. Orphanides C., Fine L.G., and Norman J.T. Hypoxia stimulates proximal tubular cell matrix production via a TGF-beta1-independent mechanism. Kidney Int 52 (1997) 637-647
54. Manotham K., Tanaka T., Matsumoto M., et al. Transdifferentiation of cultured tubular cells induced by hypoxia. Kidney Int 65 (2004) 871-880
55. Zavadil J., Cermak L., Soto-Nieves N., et al. Integration of TGF-beta/Smad and Jagged1/Notch signalling in epithelial-to-mesenchymal transition. EMBO J 23 (2004) 1155-1165
56. Modlinger P.S., Wilcox C.S., and Aslam S. Nitric oxide, oxidative stress, and progression of chronic renal failure. Semin Nephrol 24 (2004) 354-365
57. Eddy A.A. Interstitial fibrosis in hypercholesterolemic rats: Role of oxidation, matrix synthesis, and proteolytic cascades. Kidney Int 53 (1998) 1182-1189
58. Meng S., Cason G.W., Gannon A.W., et al. Oxidative stress in Dahl salt-sensitive hypertension. Hypertension 41 (2003) 1346-1352
59. Beswick R.A., Zhang H., Marable D., et al. Long-term antioxidant administration attenuates mineralocorticoid hypertension and renal inflammatory response. Hypertension 37 (2001) 781-786
60. Susztak K., Raff A.C., Schiffer M., et al. Glucose-induced reactive oxygen species cause apoptosis of podocytes and podocyte depletion at the onset of diabetic nephropathy. Diabetes 55 (2006) 225-233
61. Budisavljevic M.N., Hodge L., Barber K., et al. Oxidative stress in the pathogenesis of experimental mesangial proliferative glomerulonephritis. Am J Physiol 285 (2003) F1138-F1148
62. Nath K.A., Grande J., Croatt A., et al. Redox regulation of renal DNA synthesis, transforming growth factor-beta1 and collagen gene expression. Kidney Int 53 (1998) 367-381
63. Thannickal V.J., and Fanburg B.L. Reactive oxygen species in cell signaling. Am J Physiol 279 (2000) L1005-L1028
64. Sung F.L., Zhu T.Y., Au-Yeung K.K., et al. Enhanced MCP-1 expression during ischemia/reperfusion injury is mediated by oxidative stress and NF-kappaB. Kidney Int 62 (2002) 1160-1170
65. Satriano J.A., Shuldiner M., Hora K., et al. Oxygen radicals as second messengers for expression of the monocyte chemoattractant protein, JE/MCP-1, and the monocyte colony-stimulating factor, CSF-1, in response to tumor necrosis factor-alpha and immunoglobulin G. Evidence for involvement of reduced nicotinamide adenine dinucleotide phosphate (NADPH)-dependent oxidase. J Clin Invest 92 (1993) 1564-1571
66. Iglesias-De La Cruz M.C., Ruiz-Torres P., Alcami J., et al. Hydrogen peroxide increases extracellular matrix mRNA through TGF-beta in human mesangial cells. Kidney Int 59 (2001) 87-95
67. Rhyu D.Y., Yang Y., Ha H., et al. Role of reactive oxygen species in TGF-beta1-induced mitogen-activated protein kinase activation and epithelial-mesenchymal transition in renal tubular epithelial cells. J Am Soc Nephrol 16 (2005) 667-675
68. Geesin J.C., Hendricks L.J., Gordon J.S., et al. Modulation of collagen synthesis by growth factors: The role of ascorbate-stimulated lipid peroxidation. Arch Biochem Biophys 289 (1991) 6-11
69. Geesin J.C., Hendricks L.J., Falkenstein P.A., et al. Regulation of collagen synthesis by ascorbic acid: Characterization of the role of ascorbate-stimulated lipid peroxidation. Arch Biochem Biophys 290 (1991) 127-132
70. Houglum K., Brenner D.A., and Chojkier M. d-alpha-tocopherol inhibits collagen alpha 1(I) gene expression in cultured human fibroblasts. Modulation of constitutive collagen gene expression by lipid peroxidation. J Clin Invest 87 (1991) 2230-2235
71. Allen D.A., Harwood S., Varagunam M., et al. High glucose-induced oxidative stress causes apoptosis in proximal tubular epithelial cells and is mediated by multiple caspases. FASEB J 17 (2003) 908-910
72. Martindale J.L., and Holbrook N.J. Cellular response to oxidative stress: Signaling for suicide and survival. J Cell Physiol 192 (2002) 1-15
73. Zou A.-P., Li N., and Cowley Jr. A.W. Production and actions of superoxide in the renal medulla. Hypertension 37 (2001) 547-553
74. Brenner B.M., Cooper M.E., de Zeeuw D., et al. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N Engl J Med 345 (2001) 861-869
75. Keane W.F., Brenner B.M., de Zeeuw D., et al. The risk of developing end-stage renal disease in patients with type 2 diabetes and nephropathy: The RENAAL study. Kidney Int 63 (2003) 1499-1507
76. Rossing K., Christensen P.K., Hovind P., et al. Progression of nephropathy in type 2 diabetic patients. Kidney Int 66 (2004) 1596-1605
77. Ravani P., Tripepi G., Malberti F., et al. Asymmetrical dimethylarginine predicts progression to dialysis and death in patients with chronic kidney disease: A competing risks modeling approach. J Am Soc Nephrol 16 (2005) 2449-2455
78. Iseki K., Ikemiya Y., Iseki C., et al. Haematocrit and the risk of developing end-stage renal disease. Nephrol Dial Transplant 18 (2003) 899-905
79. Roth D., Smith R.D., Schulman G., et al. Effects of recombinant human erythropoietin on renal function in chronic renal failure predialysis patients. Am J Kidney Dis 24 (1994) 777-784
80. Kuriyama S., Tomonari H., Yoshida H., et al. Reversal of anemia by erythropoietin therapy retards the progression of chronic renal failure, especially in nondiabetic patients. Nephron 77 (1997) 176-185
81. Gouva C., Nikolopoulos P., Ioannidis J.P., et al. Treating anemia early in renal failure patients slows the decline of renal function: A randomized controlled trial. Kidney Int 66 (2004) 753-760
82. Rossert J., Levin A., Roger S.D., et al. Effect of early correction of anemia on the progression of CKD. Am J Kidney Dis 47 (2006) 738-750